Integrating network pharmacology, molecular docking, and experimental validation to reveal the mechanism of Radix Rehmanniae in psoriasis

Nian Mo,Panyu Zhou,Fanlu Liu,Haojie Su,Ling Han,Chuanjian Lu
DOI: https://doi.org/10.1097/md.0000000000040211
IF: 1.6
2024-10-30
Medicine
Abstract:Psoriasis is a highly prevalent chronic skin condition characterized by raised red patches covered with silver scales that may cause tiny bleeding spots when the scales are removed. [ 1 ] Psoriasis affects approximately 2% to 3% of the global population, [ 2 ] with the greatest occurrence observed in developed European nations. [ 3 , 4 ] Chronic skin conditions can manifest at any stage of life. Episodes were more frequent at ages 16 to 22 and 55 to 60 years. Psoriasis has different clinical phenotypes, and the majority of patients with psoriasis suffer from a significant psychological and emotional burden due to larger lesions or occurrence in critical functional areas (e.g., face and genitals), and are more prone to depression, in severe cases, suicidal thoughts, and behavior. [ 5 , 6 ] Furthermore, apart from its negative impacts on physical appearance, psoriasis is linked to cardiovascular disease, metabolic disorders, and renal disease, which is referred to as inflammatory dermatosis. [ 7 ] According to the literature, people with psoriasis have a shorter life expectancy than the general population. [ 8 ] Moreover, it is costly for both the healthcare system and the patient. [ 9 ] Although significant advances have been made in treating severe psoriasis using biologics, the implications of their long-term use are not entirely clear. Chinese medicine has gained increasing attention in recent years because of its distinctive effectiveness and comparatively safe approach for treating psoriasis.
medicine, general & internal
What problem does this paper attempt to address?